about
Comparative monotherapy trials and the clinical treatment of epilepsyOxidative stress and epilepsy: literature reviewA Drosophila systems model of pentylenetetrazole induced locomotor plasticity responsive to antiepileptic drugs.Post-traumatic seizures exacerbate histopathological damage after fluid-percussion brain injury.Advancing the medical management of epilepsy: disease modification and pharmacogenetics.Post-traumatic seizure susceptibility is attenuated by hypothermia therapy.The role of psychosocial stress in the onset and progression of bipolar disorder and its comorbidities: the need for earlier and alternative modes of therapeutic intervention.The pharmacokinetics of antiepileptic drugs in rats: consequences for maintaining effective drug levels during prolonged drug administration in rat models of epilepsy.On the hypes and falls in neuroprotection: targeting the NMDA receptor.Epilepsy following cortical injury: cellular and molecular mechanisms as targets for potential prophylaxis.Disease modification in epilepsy: from animal models to clinical applications.Neuroinflammation in epileptogenesis: Insights and translational perspectives from new models of epilepsy.Differential effects of rapamycin treatment on tonic and phasic GABAergic inhibition in dentate granule cells after focal brain injury in mice.Progression from frontal-parietal to mesial-temporal epilepsy after fluid percussion injury in the ratEffects of Rapamycin Treatment on Neurogenesis and Synaptic Reorganization in the Dentate Gyrus after Controlled Cortical Impact Injury in Mice.Post-traumatic epilepsy following fluid percussion injury in the rat.Protective effects of some statins on epileptogenesis and depressive-like behavior in WAG/Rij rats, a genetic animal model of absence epilepsy.
P2860
Q24673196-45066418-485D-42ED-AFF2-AF0465723CEFQ26996304-FC852445-4826-4999-8AB9-31465FCD4F7AQ30486566-D20038CD-C464-4EB3-82C0-4EE0BDAC96DDQ34483261-05FCFAD9-9030-4ED8-8087-9C18F5BE1EA5Q34579490-67A669E8-1C85-4ED8-B5A7-AD5636B5114CQ34685723-D3C7216C-8A82-46CD-BF27-513DCB8FF7E7Q36634431-3B561AF8-CAF5-492B-B061-4BDF86B12A67Q36794851-A6A36917-D27C-43D5-86FD-356EF16FA4CBQ36958209-07AC8B64-AC87-49DC-93D8-76D2704E737BQ37383521-CD1649C6-D1B1-40FB-BD84-2DCD6A63D44BQ38450069-961F4C9E-612F-49AA-9C17-247E9EB9E6C6Q38694553-B348E613-3E18-4139-87AD-A9CF63BEBD60Q41142779-8F81659D-2A0A-4413-A741-5F66A581842CQ41481038-DAAB2691-53A9-4D6E-9816-27806BBA5147Q41863195-1E80584D-6DBB-4755-BFFF-90FA09263286Q41868793-9E7BD954-C102-442D-9952-617EC4E6F280Q48267220-42732F2A-6E2E-40B5-B482-14A62583BE87
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Antiepileptogenic agents: how close are we?
@ast
Antiepileptogenic agents: how close are we?
@en
Antiepileptogenic agents: how close are we?
@nl
type
label
Antiepileptogenic agents: how close are we?
@ast
Antiepileptogenic agents: how close are we?
@en
Antiepileptogenic agents: how close are we?
@nl
prefLabel
Antiepileptogenic agents: how close are we?
@ast
Antiepileptogenic agents: how close are we?
@en
Antiepileptogenic agents: how close are we?
@nl
P2093
P1433
P1476
Antiepileptogenic agents: how close are we?
@en
P2093
P304
P356
10.2165/00003495-200161080-00002
P577
2001-01-01T00:00:00Z
P6179
1051493254